BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23055200)

  • 1. High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Hu BS; Zhao G; Yu HF; Chen K; Dong JH; Tan JW
    Tumour Biol; 2013 Feb; 34(1):271-6. PubMed ID: 23055200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
    J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma.
    Zhang Y; Zha TZ; Hu BS; Jiang C; Ge ZJ; Zhang K; Tan YF
    Surgeon; 2013 Apr; 11(2):67-71. PubMed ID: 22878099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
    Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
    BMC Cancer; 2013 Jun; 13():306. PubMed ID: 23800357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
    Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy.
    Yang S; Yan HL; Tao QF; Yuan SX; Tang GN; Yang Y; Wang LL; Zhang YL; Sun SH; Zhou WP
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):109-16. PubMed ID: 24240726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.
    Xieraili M; Yasen M; Mogushi K; Obulhasim G; Mayinuer A; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
    Cancer Sci; 2012 Aug; 103(8):1493-501. PubMed ID: 22530999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma.
    Li W; Cai HX; Ge XM; Li K; Xu WD; Shi WH
    Tumour Biol; 2013 Apr; 34(2):669-74. PubMed ID: 23179403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients.
    Yang H; Xu M; Chi X; Yan Q; Wang Y; Xu W; Zhuang K; Li A; Liu S
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):554-563. PubMed ID: 28363424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis.
    Kim J; Hong SJ; Park JH; Park SY; Kim SW; Cho EY; Do IG; Joh JW; Kim DS
    Oncol Rep; 2009 Jun; 21(6):1449-54. PubMed ID: 19424622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.
    Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X
    Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.